health - "cancer"

MONDAY, June 2 (HealthDay News) -- Long-term smokers treated for advanced colon cancer are at increased risk for cancer recurrence, a Dana-Farber cancer Institute study shows. Researchers analyzed dat...

Surprising research suggests that childhood cancer is most common in the Northeast, results that even caught experts off guard. ...

Scientists have identified distinct clusters of genetic markers associated with the likelihood of success or failure of two smoking cessation treatments, nicotine replacement therapy (NRT) and the medication bupropion (Zyban). This study, supported by the National Institute on Drug Abuse (NIDA) and the National cancer Institute (NCI), part of the National Institutes of health (NIH), was published in the June issue of the journal Archives of General Psychiatry.

Treating pancreatic cancer with a combination of chemotherapy, biotherapy and radiotherapy prior to surgery is safe and may be beneficial for patients, according to a University of Pittsburgh cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

Scientists have identified distinct clusters of genetic markers associated with the likelihood of success or failure of two smoking cessation treatments, nicotine replacement therapy (NRT) and the medication bupropion (Zyban). This study, supported by the National Institute on Drug Abuse (NIDA) and the National cancer Institute (NCI), part of the National Institutes of health (NIH), was published in the June issue of the journal Archives of General Psychiatry.

CHICAGO (Reuters) - A cancer vaccine more than doubled the survival time of people with the most common and deadly type of brain tumor, U.S. researchers said on Monday.

AP - Bravery in the face of cancer? Sen. Edward M. Kennedy has given it new meaning. Few things require as much courage as being wide awake and aware, lying perfectly still for hours, while surgeons methodically slice out bits of your brain.

AP - Dr. John Sampson has spent most of his career studying brain tumors. And if diagnosed with the kind of cancer now faced by Sen. Edward Kennedy, he'd pick Duke University colleague Allan Friedman for a doctor.

Affymetrix Inc. (Nasdaq: AFFX) announced that its technology powers the Ipsogen MapQuant DxT Genomic Grade, the first genomic test designed to provide a more precise measurement of tumor grade than previous techniques. Ipsogen, a leading French molecular diagnostic company, launched the test, which resulted from the Powered by AffymetrixT agreement signed in August 2007.

Surprising research suggests that childhood cancer is most common in the Northeast, results that even caught experts off-guard. But some specialists say it could just reflect differences in reporting.